Introduction
Streptomycin has now been widely used in America for some years, and in this country it is gaining increasing prominence. The already voluminous literature concerning it includes several reports embodying large series of cases,1*4 and it is to such reports that we must turn f?r authoritative opinions. Nevertheless, as a consequence of the foundation of knowledge provided by others, it is possible to extract something of value from a study of small groups of cases. It is on these grounds that this paper may have some justification.
At Bangour Hospital 39 patients suffering from tuberculosis had been admitted for streptomycin treatment before 30th September *948 and these form the material for this paper.
Meningeal Tuberculosis
Twenty-seven cases suffered from meningeal tuberculosis at the time of their admission and the results of treatment assessed on 3ist October are shown in Table I .
As one would expect, with
Prolongation of the observation period the mortality rate has increased. Case D. After 3 months' streptomycin.
Little improvement. At termination of streptomycin treatment. Improved but parenchymal lesions still present. (Fig. 11) .
He made a satisfactory clinical response to streptomycin treatment but at the time of completion of treatment his chest X-ray, while improved, was not clear (Fig. 12) . A subsequent X-ray taken three months after cessation of streptomycin treatment showed further clearing, only residual pleural thickening being evident (Fig. 13) All 3 cases remain alive fifteen to seventeen months after their admission.
In 2 cases (Case 1 and Case 3) the ultimate progress remains poor, while in one the outlook for the future is reasonably good.
During the four-month period of treatment each case showed a radiographic improvement which could be described as moderate or marked.
The maximum improvement was noted in the first two months : during the last two months of treatment the X-ray appearances were either stationary or showed slight improvement. A similar trend was appreciable in respect of the clinical and laboratory findings?-improvement mainly in the first two months ; slight improvement or even deterioration in the second two months (see Table VI 
